Home News

First nine months 2020 results presentation

Operating income, growth figures, profitability and how our products have behaved.

Thu, 05/11/2020 - 00:00 0 min
Download related document
No votes yet
 
Related
The Journal npj Schizophrenia Publishes the Results of the PRISMA-3 Study of...
Today, Laboratorios Farmacéuticos Rovi, S.A. (www.rovi.es) has announced the online publication of the results of the pivotal study PRISMA-...
4 min
27/11/2020
The Spanish Prime Minister, Pedro Sánchez, makes an institutional visit to ROVI’s facility in San Sebastián de los Reyes (Madrid)
The Spanish Prime Minister, Pedro Sánchez, makes an institutional visit to ROVI...
This morning, the facility of Laboratorios Farmacéuticos ROVI, S.A. (ROVI) in San Sebastián de los Reyes (Madrid) received an...
3 min
26/11/2020
ROVI reports operating revenue growth of 12% and net profit growth of 53%
ROVI reports operating revenue growth of 12% and net profit growth of 53%
Today, Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical company specialising and engaging in the...
5 min
24/11/2020